Kirby Institute

🇦🇺Australia

Country: 🇦🇺Australia

Ownership: Private

Established: 1986-01-01

Employees: 101

Market Cap: -

Website: https://kirby.unsw.edu.au

Clinical Trials

Antiretroviral Therapy Intensification With Raltegravir or Addition of Hyper-immune Bovine Colostrum in HIV-1 Infected Patients With Suboptimal CD4+ T Cell Response

Phase 4

Completed

Conditions: HIV Infections

Interventions: Drug: raltegravir and hyper-immune bovine colostrum
Drug: Hyper-immune Bovine Colostrum
Other: raltegravir placebo
Drug: Raltegravir
Other: Hyper-immune Bovine Colostrum placebo

First Posted Date: 2008-10-15

Last Posted Date: 2012-08-24

Lead Sponsor: Kirby Institute

Target Recruit Count: 75

Registration Number: NCT00772590

Hepatitis B Acceptability and Vaccination Incentive Trial

Not Applicable

Completed

Conditions: Hepatitis B

Interventions: Other: Incentive condition

First Posted Date: 2008-08-29

Last Posted Date: 2011-06-16

Lead Sponsor: Kirby Institute

Target Recruit Count: 204

Registration Number: NCT00744289

Locations: 🇦🇺
The Kirby Institute, Sydney, New South Wales, Australia

The Effect of Raltegravir on HIV Decay During Primary and Chronic Infection

Not Applicable

Completed

Conditions: HIV Infection

Interventions: Drug: Tenofovir + emtricitabine + raltegravir.

First Posted Date: 2008-03-24

Last Posted Date: 2017-08-31

Lead Sponsor: Kirby Institute

Target Recruit Count: 16

Registration Number: NCT00641641

Locations: 🇦🇺
407 Doctors, Sydney, New South Wales, Australia
🇦🇺
Holdsworth House Medical Practice, Sydney, New South Wales, Australia
🇦🇺
St Vincent's Hospital, Darlinghurst, Sydney, New South Wales, Australia

and more 1 locations

A Prospective Study to Examine the Effectiveness and Safety of Antivirals in Volunteers Who Receive Short-term Prophylaxis Against Pandemic Influenza

Withdrawn

Conditions: Pandemic Influenza

First Posted Date: 2008-03-21

Last Posted Date: 2012-04-24

Lead Sponsor: Kirby Institute

Registration Number: NCT00640874

Locations: 🇦🇺
St Vincent's Hospital, Sydney, New South Wales, Australia
🇦🇺
Prince of Wales Hospital, Sydney, New South Wales, Australia
🇦🇺
Westmead Hospital, Sydney, New South Wales, Australia

and more 5 locations

A Prospective Study to Examine the Effectiveness and Safety of Neuraminidase Inhibitors in Index Cases With Presumed Pandemic Influenza

Withdrawn

Conditions: Pandemic Influenza

First Posted Date: 2008-03-21

Last Posted Date: 2012-04-24

Lead Sponsor: Kirby Institute

Registration Number: NCT00640302

Locations: 🇦🇺
Flinders Medical Centre, Adelaide, South Australia, Australia
🇦🇺
Royal Adelaide Hospital, Adelaide, South Australia, Australia
🇦🇺
Royal Brisbane Hospital, Brisbane, Queensland, Australia

and more 5 locations

A Prospective Study to Examine the Effectiveness and Safety of Neuraminidase Inhibitors in Volunteers Who Receive Long-term Prophylaxis Against Pandemic Influenza: PIPET B

Withdrawn

Conditions: Pandemic Influenza

First Posted Date: 2008-03-21

Last Posted Date: 2012-04-24

Lead Sponsor: Kirby Institute

Registration Number: NCT00640211

Locations: 🇦🇺
Royal Adelaide Hospital, Adelaide, South Australia, Australia
🇦🇺
St Vincent's Hospital, Sydney, New South Wales, Australia
🇦🇺
Prince of Wales Hospital, Sydney, New South Wales, Australia

and more 5 locations

ALTAIR - Alternative Antiretroviral Strategies : a Comparison of Three Initial Regimens

Phase 4

Completed

Conditions: Human Immunodeficiency Virus (HIV)

Interventions: Drug: Truvada (fixed dose combination of tenofovir + emtricitabine) + Stocrin (efavirenz)
Drug: Truvada (fixed dose combination of tenofovir + emtricitabine)+ ritonavir/atazanavir (r/ATV)
Drug: Truvada (fixed dose combination of tenofovir + emtricitabine) + zidovudine (ZDV) + abacavir (ABC)

First Posted Date: 2006-06-09

Last Posted Date: 2019-09-26

Lead Sponsor: Kirby Institute

Target Recruit Count: 329

Registration Number: NCT00335322

Thai Prophylactic HIV Vaccine Phase I Study

Phase 1

Terminated

Conditions: HIV

Interventions: Biological: pHIS-HIV-AE (DNA vaccine) prime and rFPV-HIV-AE (recombinant fowlpox virus boost) vaccine

First Posted Date: 2006-06-05

Last Posted Date: 2012-06-13

Lead Sponsor: Kirby Institute

Target Recruit Count: 8

Registration Number: NCT00333424

Locations: 🇹🇭
HIV-NAT (The HIV Netherlands Australia Thailand Research Collaboration), Thai Red Cross AIDS Research Centre, Bangkok, Thailand

ITV Extension Study

Phase 1

Completed

Conditions: HIV

First Posted Date: 2006-06-02

Last Posted Date: 2007-02-27

Lead Sponsor: Kirby Institute

Target Recruit Count: 35

Registration Number: NCT00332930

Locations: 🇦🇺
407 Doctors, Sydney, New South Wales, Australia
🇦🇺
Holdsworth House Medical Practice, Sydney, New South Wales, Australia
🇦🇺
The Alfred Hospital, Melbourne, Victoria, Australia

and more 3 locations

Can Resistance Enhance Selection of Treatment? (CREST)

Phase 4

Completed

Conditions: HIV Infection

First Posted Date: 2005-12-07

Last Posted Date: 2006-06-09

Lead Sponsor: Kirby Institute

Target Recruit Count: 300

Registration Number: NCT00262717

Locations: 🇦🇺
Sydney Sexual Health Clinic, Sydney, New South Wales, Australia
🇦🇺
Holdsworth House General Practice, Sydney, New South Wales, Australia
🇦🇺
Prince of Wales Hospital, Sydney, New South Wales, Australia

and more 16 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy